Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.44
-0.0100-0.69%
Post-market: 1.440.00000.00%16:10 EDT
Volume:497.24K
Turnover:728.53K
Market Cap:103.61M
PE:-0.46
High:1.55
Open:1.46
Low:1.42
Close:1.45
52wk High:5.44
52wk Low:1.01
Shares:71.95M
Float Shares:49.79M
Volume Ratio:0.88
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1454
EPS(LYR):-2.3331
ROE:-49.55%
ROA:-25.41%
PB:0.38
PE(LYR):-0.62

Loading ...

Guggenheim Remains a Buy on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
Aug 07

Zentalis Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 07

Zentalis Pharma Q2 EPS $(0.37) Beats $(0.51) Estimate, $303.4M Cash, Cash Equivalents And Marketable Securities Supports Operational Runway Into Late 2027

Benzinga
·
Aug 07

Zentalis Pharma's Q2 operating expenses down

Reuters
·
Aug 07

Zentalis Pharmaceuticals Q2 Net Income USD -26.874 Million

THOMSON REUTERS
·
Aug 07

Zentalis Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Aug 05

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jul 02

Zentalis Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 19

Zentalis Pharmaceuticals Inc. to Present at Jefferies Healthcare Conference in New York

Reuters
·
May 20

Zentalis Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 15

Zentalis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

Benzinga
·
May 15

BRIEF-Zentalis Pharmaceuticals Q1 Operating Expenses USD 45.623 Million

Reuters
·
May 15

Zentalis Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
May 02

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

Simply Wall St.
·
Apr 29

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

GlobeNewswire
·
Apr 28

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

GlobeNewswire
·
Apr 24

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 02

Promising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals

TIPRANKS
·
Apr 01

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

TIPRANKS
·
Mar 31